v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2026
Summary of Significant Accounting Policies  
Schedule of vendor concentration risk percentage

​

​

​

​

​

​

​

​

​

​

Year Ended

 

​

​

June 30, 

 

​

​

2026

  ​

  ​

2025

​

Vendor A

​

28

%

​

27

%

Vendor B

​

11

%

​

10

%

​

Schedule of revenue by geographical region

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

​

June 30, 

​

​

​

2026

 

​

2025

​

United States

​

$

27,231,305

  ​ ​ ​

56.4

%  

​

$

28,213,701

​

57.5

%

Europe

​

 

15,942,672

 

33.0

%  

​

 

15,689,693

 

32.0

%

Rest of World

​

 

5,132,980

 

10.6

%  

​

 

5,154,587

 

10.5

%

Total

​

$

48,306,957

 

100

%  

​

$

49,057,981

 

100

%

Schedule of accounts receivable net by geographical region

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

 

​

​

June 30, 

 

​

​

2026

 

​

2025

​

United States

  ​ ​ ​

$

3,822,084

  ​ ​ ​

54.9

%  

​

$

4,033,807

​

56.1

%

Europe

​

 

2,226,167

 

32.0

%  

​

 

2,413,906

 

33.6

%

Rest of World

​

 

914,789

 

13.1

%  

​

 

743,521

 

10.3

%

Total

​

$

6,963,040

 

100

%  

​

$

7,191,234

 

100

%

Schedule of segment reporting information

​

​

​

​

​

​

​

​

​

​

Year ended June 30,

​

​

2026

  ​ ​ ​

2025

Revenue

​

$

48,306,957

​

$

49,057,981

Cost of revenue

​

 

23,236,449

​

 

24,862,030

Gross profit

​

 

25,070,508

​

 

24,195,951

Gross profit margin

​

 

51.9%

​

 

49.3%

Selling, general and administrative expenses:

​

 

​

​

​

​

Sales and marketing

​

​

6,397,899

​

​

5,360,356

Technology and product development

​

 

6,121,647

​

 

5,631,344

General and administrative

​

 

6,724,399

​

 

7,936,644

Stock-based compensation expense

​

 

928,516

​

 

1,723,561

Foreign currency transaction loss (gain)

​

 

54,697

​

 

(202,527)

Total selling, general and administrative expenses

​

 

20,227,158

​

 

20,449,378

Depreciation and amortization

​

​

1,254,973

​

​

1,245,362

Net income

​

$

2,822,068

​

$

1,265,553

​

​

​

​

​

​

​

​

​

​

Year ended June 30,

​

​

2026

  ​ ​ ​

2025

Cash and cash equivalents

​

$

12,630,283

  ​ ​ ​

$

12,227,312

Current assets, excluding cash and cash equivalents

​

 

8,063,885

 

​

7,772,416

Long term assets

​

 

24,970,550

 

​

26,120,946

Total segment assets

​

$

45,664,718

 

$

46,120,674

Schedule of basic and diluted earnings per share

​

​

​

​

​

​

​

​

​

​

​

​

Years Ended

​

​

​

June 30,

​

  ​ ​ ​

  ​ ​ ​

2026

  ​ ​ ​

2025

Net income available to common shareholders

​

​

$

2,822,068

​

$

1,265,553

​

​

​

​

​

​

​

​

Weighted average commons shares - basic

​

​

 

31,788,992

​

 

30,681,187

Dilutive effect of outstanding stock options

​

​

 

465,981

​

 

822,785

Dilutive effect of unvested restricted common stock

​

​

 

17,862

​

 

—

Weighted average commons shares - diluted

​

​

 

32,272,835

​

 

31,503,972

​

​

​

​

​

​

​

​

Net income per common share:

​

​

 

​

​

​

​

Basic

​

​

$

0.09

​

$

0.04

Diluted

​

​

$

0.09

​

$

0.04

Schedule of Company's assets and liabilities at fair value

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of June 30, 2026

​

As of June 30, 2025

​

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

  ​ ​ ​

Total

​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

 

​

  ​

Assets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total assets

​

$

—

​

$

—

​

$

—

 

$

—

​

$

—

​

$

—

​

$

—

 

$

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Liabilities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contingent earnout liability

​

$

—

​

​

—

​

$

7,323,314

​

$

7,323,314

​

$

—

​

​

—

​

$

14,046,640

​

$

14,046,640

Total liabilities

​

$

—

​

$

—

​

$

7,323,314

 

$

7,323,314

​

$

—

​

$

—

​

$

14,046,640

 

$

14,046,640

Schedule of company's contingent earnout liability activity

​

​

​

​

​

​

​

​

​

​

Years Ended

​

​

June 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Beginning balance, contingent earnout liability

​

$

14,046,640

​

$

12,298,114

​

​

​

​

​

​

​

Change in fair value of contingent earnout liability

​

 

—

​

 

1,748,526

Accreted interest expense

​

 

1,040,293

​

 

—

Scite earnout payments in cash

​

 

(4,856,763)

​

 

—

Scite earnout payments in shares of common stock

​

 

(2,906,856)

​

 

—

Ending balance, contingent earnout liability

​

$

7,323,314

​

$

14,046,640

​

​

​

​

​

​

​